{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-109585","form_type":"8-K","ticker":"SNYR","cik":"0001562733","company_name":"Synergy CHC Corp.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.748834+00:00","generated_at":"2026-05-16T20:21:04.000295+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Synergy CHC Q3 revenue $8.0M (+12.4%); net income falls to $125K from $784K","bullets":["Revenue $8.0M (+12.4% YoY); gross margin expanded to 70.9% from 67.2%.","Net income $125.3K ($0.01 EPS) vs $783.6K ($0.11 EPS); operating income $1.28M (+21.8%).","Adjusted EBITDA $1.52M (+13.4%); cash $1.0M; working capital surplus $16.68M after liability reduction.","New retail placements with Kroger, Wakefern; $4.4M public offering closed in August.","Appointed former Costco exec Teresa Thompson to Board; FOCUSfactor #1 Pharmacist Recommended post-quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-109585","json":"https://secwatch.observer/filing/0001213900-25-109585.json","markdown":"https://secwatch.observer/filing/0001213900-25-109585.md","text":"https://secwatch.observer/filing/0001213900-25-109585.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1562733/000121390025109585/0001213900-25-109585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1562733/000121390025109585/ea0265292-8k_synergy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:21:04.000295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}